Ticker Scorecard - SGMO Basics Company: Sangamo Therapeutics, Inc. IPO Date: April 6, 2000 Sector: Healthcare Industry: Biotech Market Cap: $223.25M Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 3.24% Avg Daily Range (30 D): $0.04 | 3.67% Avg Daily Range (90 D): $0.10 | 5.67% Institutional Daily Volume Avg Daily Volume: 1.08M Avg Daily Volume (30 D): 4.01M Avg Daily Volume (90 D): 7.64M Trade Size Avg Trade Size (Sh.): 205 Avg Trade Size (Sh.) (30 D): 406 Avg Trade Size (Sh.) (90 D): 412 Institutional Trades Total Inst.Trades: 2,765 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $.83M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.72M Avg Closing Trade (30 D): $.88M Avg Closing Trade (90 D): $1.91M Avg Closing Volume: 209.38K     News Feb 21, 2025 @ 6:00 PM Cell and Gene Therapies in Rare Disorders Market t... Source: Delveinsight Jan 2, 2025 @ 7:30 AM Global Mucopolysaccharidosis Treatment Market to W... Source: Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.) Dec 31, 2024 @ 2:14 PM Sangamo Therapeutics Stock Plunges As Pfizer Termi... Source: Vandana Singh Dec 8, 2024 @ 1:00 PM mRNA Therapeutics Market Size to Hit USD 48.65 Bil... Source: Sns Insider Nov 22, 2024 @ 7:27 AM Gene Panel Market to Surpass USD 11.75 Billion by ... Source: Skyquest Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.71 $.05 $-.18 Diluted EPS $-.71 $.04 $-.18 Revenue $ 52.29M $ 49.41M $ .36M Gross Profit $ $ $ Net Income / Loss $ -134.84M $ 10.67M $ -36.13M Operating Income / Loss $ -140.04M $ 10.63M $ -37.08M Cost of Revenue $ $ $ Net Cash Flow $ -17.31M $ 12.92M $ -27.55M PE Ratio